ONO PHARMACEUTI/ADR (OTCMKTS:OPHLY) was down 0.5% during mid-day trading on Tuesday . The stock traded as low as $7.50 and last traded at $7.50, approximately 2,265 shares were traded during mid-day trading. A decline of 88% from the average daily volume of 19,242 shares. The stock had previously closed at $7.53.

Separately, Jefferies Financial Group started coverage on shares of ONO PHARMACEUTI/ADR in a research note on Tuesday, September 24th. They issued a “hold” rating on the stock.

The company’s 50 day simple moving average is $6.43 and its 200-day simple moving average is $6.14.


Ono Pharmaceutical Co, Ltd. produces and sells pharmaceuticals and diagnostic reagents worldwide. Its products include OPDIVO intravenous infusions for the treatment of malignant tumor; KYPROLIS, a proteasome inhibitor for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; GLACTIV and FORXIGA tablets for type 2 diabetes; KINEDAK tablets to treat diabetic peripheral neuropathy; PARSABIV, an intravenous injection for dialysis patients; RECALBON tablets to treat osteoporosis; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; ONOACT injections for treating tachyarrhythmia; Staybla tablets for overactive bladder; OPALMON tablets to treat peripheral circulatory disorder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; and Foipan tablets to treat chronic pancreatitis and postoperative reflux esophagitis.

Featured Article: What is range trading?

Receive News & Ratings for ONO PHARMACEUTI/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ONO PHARMACEUTI/ADR and related companies with MarketBeat.com's FREE daily email newsletter.